It is well-recognized that, despite similar pain characteristics, some people with chronic pain recover, whereas others do not. In this review, we discuss possible contributions and interactions of biological, social, and psychological perturbations that underlie the evolution of treatment-resistant chronic pain. Behavior and brain are intimately implicated in the production and maintenance of perception. Our understandings of potential mechanisms that produce or exacerbate persistent pain remain relatively unclear. We provide an overview of these interactions and how differences in relative contribution of dimensions such as stress, age, genetics, environment, and immune responsivity may produce different risk profiles for disease development, pain severity, and chronicity. We propose the concept of "stickiness" as a soubriquet for capturing the multiple influences on the persistence of pain and pain behavior, and their stubborn resistance to therapeutic intervention. We then focus on the neurobiology of reward and aversion to address how alterations in synaptic complexity, neural networks, and systems (eg, opioidergic and dopaminergic) may contribute to pain stickiness. Finally, we propose an integration of the neurobiological with what is known about environmental and social demands on pain behavior and explore treatment approaches based on the nature of the individual's vulnerability to or protection from allostatic load.
Introduction
What are the factors that determine why, after a similar insult, some people experience pain that resolves while in others it persists? An analysis of this question requires the ability to define chronic pain in such a way that it can be distinguished mechanistically from acute pain-pain that abates naturally after injury. We need an approach to understanding why, in the context of similar physical insult, some individuals develop chronic pain, whereas others experience limited or rapidly resolving pain. Historically, chronic pain has been defined in terms of its duration: this definition does not allow for a consideration of mechanism. Thus, in some patients, eliminating the causative insult, or modifying the process with effective treatment, even after years of pain, leads to pain resolution. In others, there appears over time a dissociation of the causative insult and the continued pain, and/ or a resistance to therapies that may have initially been quite effective.
Although significant numbers of individuals suffer from chronic pain, reportedly more than 100 million in the United States alone, 121 a more careful analysis suggests that fewer have daily pain (some 25 million in the United States), and fewer still have severe pain (14 million in the United States). 196 The number of people with persistent pain who are unresponsive to treatment are not easily determined nor reported in large epidemiological studies. But treatment failure is high at the level of the trial so is likely to be worse in the clinic. Treatment failure is inferred from data derived from controlled trials (eg, for gabapentin and neuropathic pain) where the treatment can provide relief as high as 50% of pain intensity in comparison with placebo, normally expressed in terms of the mean. 192 Arguably, the high burden of pain in the population and limited treatment options have meant that more radical treatments are being proposed, including ketamine infusions, 182 and deep 23 or transcranial 156 brain stimulation, all offered to patients with pain described as treatment resistant. The picture is one of a large population of people with treatment-resistant, complex, burdensome pain for which we struggle to find viable long-term analgesic or pain management options.
In this article, we propose the concept of "stickiness" as a soubriquet for capturing the multiple influences on the persistence of pain and pain behavior, and their stubborn resistance to therapeutic intervention. Our ultimate goal, perhaps a goal of the whole field of pain research, is to develop a fully integrated biobehavioral model. However, this first step toward that goal is a neurobiological one. We explore the idea of pain stickiness in the following sections: In (1) the section on "Perturbations of Biological Systems and the Development of Chronic Pain," we evaluate the idea of how an event or
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perturbation (eg, surgery) may induce changes in a system to which there is a response that may be adaptive or maladaptive (through numerous influences) and which may result in chronic pain as a result of changes in behavior; (2) the section that follows, entitled "Pain Stickiness: Clinical Insights," we provide examples of pain chronification where pain load, as defined by intensity and duration may produce a more resistant pain state less easily modified or affected by therapeutic interventions; (3) the third section provides an overview of elements that contribute to our understanding of "Neurobiology of Pain Stickiness" including synaptic plasticity, stress, brain circuits, endogenous regulators (namely opioidergic and dopaminergic) that may contribute to the "stuck" pain state (ie, nonresponders); and (4) the final section "Pain Unstuck: Potential Research Targets," we focus on potential novel therapeutics arising from this approach.
Perturbations of biological systems and the development of chronic pain
Systems biology, including the neurobiology of chronic pain, starts from the premise of expected complexity and relegates most of this intricacy to error variance. We start with the assumption that it is theoretically possible for all people to develop chronic pain. In practice, however, not everyone does develop chronic pain. For a perturbation such as nerve damage after surgery, eg, some 15% to 50% of patients may have pain, of whom 10% to 15% experience severe, unremitting pain. What differentiates responses to the same perturbation? Perturbations may take place at genetic, 272 cellular, 85, 139 neuronal, whole brain systems, 36 and at psychological 79 levels. This is represented in the field of "Network Biology" 11, 113 that can model complex behaviors. Modeling of such a multifactorial entity as pain may be thus substantially aided by its conceptualization as a computable network. Through increased understanding of biological systems and the application of computational methods, our ability to model a complex process such as chronic pain is becoming more likely. In doing so, systems can be simulated with adaptive and maladaptive functional properties defined. It should be noted that perturbations may induce regulatory networks that include inhibition/repression or stimulation/expression of multiple processes. This is reflected in chronic pain as perturbations that contribute to protection from perturbation and resilience to prolonged disruption.
Reaction to injury or the threat of injury is characterized by the attempts of the organism to return or maintain homeostasis. This reaction can turn into action (without external reference) and "overrun," creating a state of allostasis, which may prevail where normal adaptations to pain are not working. 27 The behavioral response, whether to pain induced by peripheral nerve damage (eg, surgery), spinal cord damage, alterations in the brain itself (depression and thalamic stroke), or through repetitive avoidance or endurance behavior, 53, 54 results in alterations of a normal ecosystem that involve brain connections. The latter, termed the connectome, defines our behavioral state including that in acute and chronic pain. 152 We are interested in adaptive systems, in the ability to repeatedly respond to a stressor such as persistent pain in ways that produce consistent outcomes. Behavioral response to stress is commonly called "coping," 263 but this is sometimes poorly defined, conflating behavior with outcome. 240 Here, we are interested in the elastic property of the system to return the organism to homeostasis, and in this regard choose to describe that property as a form of "resilience." There are many ways to consider resilience in the context of pain or the threat of pain, including the cognitive, 205 emotional, 88, 132 genetic, 90 and epigenetic. 71 
Cognitive-affective influences
Coping with chronic pain is often associated with the ability to recast a problem in a broader frame of possible solutions, in which worry promotes problem solving rather than rumination. 59, 69, 73, 75 Less explored is the fate of pain interruption, and by extension the capturing of motivational systems by pain. 6, 54, 191 Multidimensional psychological constructs of the affective interpretation of pain have been widely explored. Fear and avoidance behavior are implicated in repetitive chronic pain behavior, 53, 135, 249, 264 at least in patients presenting with chronic pain, as is the appraisal of pain and its consequences as unavoidably catastrophic. 243, 273 Attempts to characterize successful coping behavior as a property of a system's resilience are hampered by a conceptual circularity inherent in clinical observational studies that focus on measuring observable outcomes. We are confident, however, that the salience of the affective tone of interruption is a crucial component in the system's response to threat. 79 
Demographic/socioeconomic influences on chronic pain
Social and demographic factors, including sex, gender, age, marital status, family relations, or socioeconomic status (SES) are all important elements of the context for pain experience. 1, 201 Effects of SES on pain are reported for other common pain conditions such as headache 178 or chronic pain after a motor vehicle accident. 265 In addition to the more well-defined biological factors, the multitude of influences on an individual's pain, as noted in this article, are complex and also include socioeconomic (poverty, access to health care including affordability of medications and occupation type), demographic (eg, age, sex, and education), and pain-specific factors (eg, surgical treatment outcomes). For example, "Lower individual and community SES are both associated with worse function and pain among adults with knee rheumatoid arthritis". 46 In a consideration of allostasis, poor SES could contribute to increased pain. 241 As such, the effects of poverty are associated with increased allostatic load, 227 the accumulation of stressors threatening physiological homeostasis. The processes contributing to allostatic load can add to the burden of health status through the maladaptive responses to chronic stress imposed by SES. 140 Allostasis (see below) may contribute to socioeconomic load of chronic pain and to disease comorbidity associated with chronic pain. With respect to the first, allostatic load may influence patterns of pain prevalence. 241 In addition, many countries are seeing a relative aging of the population. In the United States, eg, the number of Americans older than 65 years has increased steadily because of the rise in life expectancy and is projected to encompass one-fifth of the population within the next 20 years. 49, 83 These patients are naturally at a heightened risk of comorbid conditions as 50% of community-dwelling elderly people and 80% of nursing home residents are suffering from chronic pain. 108 In the context of comorbidity, allostasis has been considered a concept that may link comorbid conditions. 150, 206 Comorbidity in chronic pain has been reported for multiple conditions 55 including anxiety and depression, 57 alcohol use disorder, 279 post-traumatic stress disorder, 165 pain sensitivity in opioiddependent patients, 284 and bipolar disorders. 64 For the comorbidity of pain and psychiatric disorders 269 such as comorbid anxiety, research supports the notion of increased pain levels, 96 chronification, 244 and lower treatment efficacy. 238 The notion of how psychiatric disorders may contribute to pain chronification has been reviewed previously. 31 Comorbidity focuses on the interesting phenomenon changes in the brain, in pain, in depression, and in addiction. 81 For example, in patients with major depressive disorder without a history of previous pain, some 60% present with a generalized pain disorder. 131 
Genetics-predisposition and resilience
Genetic contributions to resilience or vulnerability may be considered in a number of domains: (1) Genes that moderate the noninflammatory stress response. Ongoing high levels of corticosteroids have been associated with chronic pain. 184, 268 Genes, including FKBP5 and CRHR1 polymorphisms, have been shown to modulate or modify the response of the hypothalamicpituitary-adrenal axis. 160 These genes may shape responses to early life experience (eg, risk of PTSD after child abuse 20 ) or to new stressors such as a motor vehicle accident or sexual assault.
32 (2) Genes that sensitize the nervous system to potentially develop chronic pain. A number of genes may contribute to pain severity 276 : specific alleles have been associated with an increased risk for postsurgical pain severity and persistence. 259 Specifically, patients with chronic low-back pain expressing a haplotype of the GCH1 gene had less neuropathic pain after discectomy. Other examples of genes showing an association with chronic pain states include an amino acid-changing allele in KCNS1 52 and genes associated with certain types of headaches including migraine. 35, 60 Taken together, the genetic susceptibility to chronic pain 127, 200 contributes not only to an increased risk of pain but also may provide insights into treatment resistance and chronification. (3) Genes that may alter the immune response. Neuroinflammation seems to be a common process involved in chronic pain. 168 Genes that regulate the immune response may contribute to resilience or susceptibility to disease. The modulatory effects of neuroinflammation may be activated by a disease state such as nerve damage 80, 190 or even by adverse social conditions. 47 Resilience to neuroinflammation may itself be a protective mechanism in disease. 173 For example, a T-cell shift present in neuropathic pain may represent a protective, anti-inflammatory process. 170 
Epigenetic factors-nongenetic modification of biological responses
Biological processes are regulated by epigenetic processes that may confer vulnerability. 71, 285 Epigenetic processes take place through DNA methylation of genes (including stress-response genes) that may alter resilience to environmental stressors. The term epigenetics refers to processes that contribute to altered gene expression through nongenetic mechanisms, and these processes may have significant effects on pain. Thus epigenetic factors may contribute to pain behaviors and to the likelihood of pain becoming stuck. 62 The implications of epigenetic changes are only just becoming known and include changes in memory for pain, 213 Allostatic load may further contribute to the efficient return to homeostasis. 185 Such perturbations may either prevent or allow for the exacerbation (chronification, resistance to treatment, intensity, and comorbidity) of pain. An individual's previous and current biopsychosocial state may be important elements in the chronification and persistence of pain or may limit this process. In the next section, we discuss clinical examples of this process.
Pain stickiness: clinical insights
Most people who experience an episode of acute pain caused by deliberate, accidental, or disease related trauma do not develop chronic pain. For those who do, the extent of pain, disability, and distress are highly variable-some pain syndromes are more severe and more permanent than others. Perhaps, central neuropathic pain syndromes associated with stroke or spinal cord damage 38, 149 are examples of chronic pain that rarely, if ever, resolve. For those individuals in whom pain and maladaptive coping become rigidly fixed or "stuck," a number of factors seem to contribute to this rigidity. Below, we give a few clinical examples of increased or decreased "pain stickiness."
In Figure 1 , we represent the idea of pain evolving and persisting, remaining static, or worsening. In the schematic model, the blue portion beyond the inflection point (diamond) suggests a time where pain either persists or worsens as opposed to reversal (sliding back along the pain trajectory). Pain may not always worsen when it chronifies: some people with postoperative pain, or with pain from other (usually traumatic) causes, describe pain onset at a severe level that never eases or worsens. Clinical examples of pain stickiness are encompassed by the delayed onset and offset of pain after 2 neuropathic pain syndromes: after stroke affecting the sensory thalamus (ie, ventroposterolateral), there is a variable time for onset of pain ; after postherpetic neuralgia, time to offset of pain was reported as up to 120 months. 129 Another example is in migraine chronification where episodic migraine (#14 migraine days per month) increases in frequency to become chronic migraine ($14 migraine days per month). The transformation may be progressive or acute as in new daily persistent headache. 222 Chronic migraine is more resistant to treatment. Both the neuropathic and migraine examples speak to processes that relate to nervous system adaptation and resilience.
Analgesic efficacy and pain stickiness
Most analgesics have an NNT for 50% pain relief in chronic pain of between 3 and 10, and the superior effect of the primary drug over placebo is in the region of 30%. 193 In essence, most people treated with pharmacological interventions do not experience the desired effect. 192 It is, however, well-known that pain relief has a binomial or U-shaped distribution, meaning that describing a sample by its mean score is to choose the experience of the least number of people. 192 It is better to think more carefully about who responds and why. One reason for the ineffectiveness may relate to how drugs, when used chronically, may enhance pain. Although mechanisms are not fully understood, one example is chronic opioid use associated with increased DNA methylation and increased levels of clinical pain. 68 It should be noted, however, that some of these data should be assessed in the context of duration of treatment; for example, for opioid effects on chronic pain, the longest randomized controlled trial (RCT) is only 16 weeks. seems to induce migraine chronification. 19, 41, 126 Interestingly in many patients, chronification (transformed migraine) is reversed with drug withdrawal or decreased (ie, from chronic to episodic migraine). 111 With chronic pain characterized as "opioid-induced hyperalgesia," 280 often of rapid onset, 97 the opioid may actually be contributing to or be part of chronification, although at present, the strongest evidence is from preclinical studies. 109, 110 A similar pattern of pain exacerbation as seen in migraine and headache is observed in patients with chronic methadone use because of addiction who also show increased sensitivity to experimental and clinical pain. 210 The hypersensitivity lasts for years after methadone withdrawal. 210, 216 Taken together, these data suggest that opioids may produce a long-lasting effect on neural circuits. Recent functional magnetic resonance imaging analyses of the brain function and structure in nonmedical opioiddependent subjects 266 reported opioid-induced changes in regions implicated in the regulation of affect and impulse control, as well as in reward and motivational functions. Alteration of these latter functions is also present in chronic pain, 197 and thus, a cross-sensitization process may take place where the drug Figure 1 . Chronic pain syndromes that get "stuck." We represent the idea of pain evolving and persisting, remaining static, or worsening. Back pain: It may start as an acute process and get better or it may worsen and chronify. Eighty percent of adults will have back pain at some point, and most resolve. Twenty percent, however, go on to have chronic pain for more than a year. Risk factors, like many but not all pain conditions that relate to disease resilience in back pain, include age, fitness, pregnancy, weight, genetics, and anxiety/depression. 169 In its "stuck" form, it is difficult to treat, and the ongoing pain and disability continue to contribute to the allostatic load of the condition and its treatment resistance. Postsurgical pain: Surgery may produce damage to nerves resulting in neuropathic pain and occurs in 15% to 50% of patients. 29, 143, 174 Risk factors include genetic, 286 preoperative pain, 107 acute postoperative pain, 34 psychosocial factors such as catastrophizing 125 , surgical stress, 29 and potentially perioperative treatments including intraoperative opioids that may induce postoperative hyperalgesia. 97, 145, 281 It may be more common after certain surgeries (eg, surgery for failed back; limb amputation and mastectomy), and some surgeries may have a higher incidence because of the location of the surgery relative to certain nerves (eg, intercostal n., intervertebral n., iliohypogastric n., and divisions of the sciatic n.). Taken together, these multifactorial processes may contribute individually or in various combinations to a chronic pain syndrome that may be persistent and severe. Thalamic stroke: Few pain syndromes are as severe and persistent as the pain after thalamic (usually right sided) stroke 24 that involves the spinothalamic tract. It affects some 8% of stroke patients. 4 While the onset may be days to months after the stroke, 33 it represents a forme fruste of a "stuck" pain syndrome, and as shown in the figure, the pain intensity with onset may be progressive but usually ramps up to a very severe level. The syndrome has no socioeconomic variability, age, or sex predisposition. Other syndromes that result in severe and persistent pain also produce damage the spinothalamic tract and include spinal cord injury. 179 The figure shows a timeline vs intensity that summarizes the process in which patients may not have pain or have relatively rapid onset, in most cases, of this severe central pain syndrome. Migraine: It is an example of a pain syndrome that is intermittent (acute episodic migraine) that can increase in frequency and chronify. 142, 167 In the acute episodic form (#14 headache days a month; International Headache Society Definition 245 ), the pain and associated symptoms of the pre-ictal, peri-ictal, and post-ictal events are acute and subside completely. In chronic migraine, the pain persists ($14 headache days a month; International Headache Society Definition 245 ). Some 6 to 8 million Americans suffer from chronic migraine. 178 Migraine chronification may be considered to be due to increasing allostatic load 27 and medication overuse, 18 increased frequency of headache, and menstrual cycle amongst other things contribute to the maladaptive changes in the transition from acute episodic migraine to chronic migraine. Interestingly, some data support a reversal of the chronic state with the withdrawal of certain stressors such as opioid medication. 234 The figure shows 2 forms of migraine-acute intermittent migraines (multiple attacks) are present. In the acute form, there is an intermitted attack that recedes, usually with hours but may last up to 72 hours. In the chronic form, pain is present most of the time. Pain 1 anxiety: The notion that psychological processes (eg, fear, avoidance, and anhedonia) can affect chronic pain either as a predictor 208 because of a particular constitutional makeup or as an exacerbator of the pain condition 253 is depicted in the figure. Treatment: Treatment for chronic pain is a double-edged sword in that the drugs are frequently given for a long period without an understanding of their long-term effects on neural or other systems. In chronic pain, the field has embraced the notion of such concepts as "opioid-induced hyperalgesia" that may reflect the induction of aberrant neural systems to produce increased ongoing pain 45 and perhaps increased resistance to treatment. 17 Indeed, chronic opioids alter morphological and functional measures in patients without pain. 266 Similarly and perhaps more notable are the effects of medications including specific antimigraine drugs called triptans, on migraine progression (increased frequency) and chronification (transformed from acute episodic to chronic). 17, 166 represents the onset/event of the pain and the point from which it may improve or get worse.
represents when pain is severe and resilient to treatment and/or chronifying. is time from the onset/event. is a scale of increasing or decreasing pain as it relates to the level of resilience.
effects, in this case opioids, enhance the derangement of brain structure (morphometric measures of gray-matter volume) and functional circuits (functional connectivity). Indeed, in nonaddicts undergoing surgery, prescription opioids are reported to alter gray matter in regions involved in "reward-and affect-processing circuitry." 283 Thus, drugs that perform a "good balancing act" including buprenorphine 122 or nalbuphine 225 may have protective effects because of the receptors they target and by implication the circuits they modify. Thus, there are underlying unique responses to stress in individuals that can markedly change the manner in which an individual adapts to later stress 164 including specific clinical conditions such as pain.
Environmental influences
Finally, we know very little about environmental influences on pain, such as the effects of geolocation, temperature, altitude, light, air composition, etc. Perhaps a good example is the adverse influence of red, blue, and white light in a murine model of headache compared with green light. 202 In some environmental settings, fluorescent lights (eg, at schools) produce a red light spectrum that exacerbates migraine onset and intensity. The implications for both the built and natural environment are largely unexplored but could be substantial. 177 
The neurobiology of pain stickiness
Animal models have been increasingly used to evaluate the risk of or resilience to disease. 3, 112, 175, 224 Some models have shown large genetic differences in the development of pain. 89, 154 Although there are few pain models of resilience in use, there are others evaluating the effects of drugs including analgesics on reward and aversion in rat genetic substrains. 146 Such data inform our views on how drugs may differentially affect circuits involved in behaviors (including pain) in individuals/species with different genetic backgrounds. Epigenetic effects in early life can alter responses in adulthood, eg, through programming of the anti-inflammatory cytokine interleukin-10 (IL-10), in the nucleus accumbens, altering risk or resilience to addiction. 229 For example, neonatal handling is mimicked by pharmacological modulation of glia in adulthood with the drug ibudilast (a phosphodiesterase inhibitor 220 that increases expression of IL-10) inhibiting morphine-induced glial activation; as a result, morphine-induced place preference is inhibited. The above provided examples of how stressors may induce significant behaviors in response to pain or analgesics.
Vulnerability to chronic pain has been the subject of a number of reviews. 31, 61, 81, 84 However, less well-understood are mechanisms that produce persistent, significant levels of ongoing pain, or which exacerbate pain. There are multiple interaction factors that alter neural connectivity (Fig. 2) .
Synaptic plasticity
This is a major process relating to modulation of dendritic complexity, and by implication, brain network connectivity. Recent neurosystems research has suggested that the brain is highly plastic. Imaging studies in pain have shown alterations in gray-matter volume that may be increased or decreased in chronic pain 242 or as a result of pain relief. 28 For the most part, studies suggest a decrease in gray-matter volume in chronic pain, but specific issues such as control for age, disease duration, and/ or drug effects have not been fully assessed. The basis for alterations in gray-matter volume is the amount of change in dendritic tree complexity. Synaptic connectivity is based dendrites, structures that propagate electrical activity from other neurons to a neuron's cell body. Just as a tree in winter (no leaves, fewer branches) or summer (leaves and growing branches), dendrites are dynamic and may grow or recede. With the former, there is usually enhanced synaptic connectivity and vice versa.
Synaptic plasticity drives dendritic morphological plasticity. 195 Such changes may result in long-term alterations in circuit function. Depending on the nature of the changes, increased numbers of dendritic synapses result in synaptic amplification in response to synaptic inputs. 230 Larger dendritic spines seem to be more permanent and smaller spines more transient, 230 suggesting that memory or persistent function (ongoing activity) is related to their state and anatomy and that, without activity, the less well-formed dendritic spines may collapse. Dendrites have excitable channels, and changes in dendritic spines underlie changes in synaptic strength that may be altered, sometimes rapidly, by aging, 7 gender 187 stress, 141 pharmacological agents, the environment, and disease. Figure 3 is a cartoon of how dendritic plasticity may shape neural circuits.
Multiple processes alter dendritic morphology including cytokines and drugs. Although some cytokines may exert protective functions, 67 immune systems modulate dendritic morphology and physiology 21 and proinflammatory and antiinflammatory cytokines may have detrimental effects on the brain. 214 Drugs may also affect dendritic integrity. These changes may be considered to be morphogenic (ie, to enhance dendritic spine integrity) or antimorphogenic (ie, to induce abnormal dendritic changes). Some pharmacological agents (ie, such analgesics as amitriptyline and morphine) have seemingly beneficial effects on dendrite morphology. Amitriptyline also has a powerful neurotrophic activity. 136 Other analgesics, as well as morphine, are also believed to alter dendritic morphology 162, 246 and may be responsible for altered neural circuit function and gray-matter volume after chronic opioid use. 266 Morphine withdrawal may also reduce spine density and be persistent in nature. 65 In addition, stress-related modulators such as stress hormones (ie, cortisol) and cytokines are known to alter dendritic spines. 21 Gonadal steroids such as estradiol promote dendritic spine growth. 188 The effects of gonadal steroids on regions such as the amygdala include an increased number of spines in adult men and rapid changes of dendritic density in adult women across the estrous cycle. 215 These data are supported by rapid gray-matter changes occurring across the menstrual cycle, which seems to be driven by changes in estradiol concentrations. 56 The female brain may therefore be "at risk" of clinical conditions, including the increased prevalence of chronic pain, 13, 93 presumably because of the dynamic or changing pattern of dendritic complexity.
Stress and the hypothalamo-pituitary-adrenal axis
Given that a "…stressor pushes the physiological system away from its baseline state toward a lower utility state," 203 stress may also alter the brain. 186 Early life stress may contribute to chronic pain in adulthood 12 providing insights into the significant and long-term consequences of stress. Stress may alter immune systems 231 and produce epigenetic changes. 247 Chronic corticosteroid release alters the brain in a significant manner, including the hippocampal system, a brain region believed to be part of the brain's stress-response system. 58 Such a relationship has been reported in migraine 176 and chronic pain. 194, 268 A number of neural mechanisms are involved in stress (including pain) resilience and vulnerability, including the neuroendocrine system, and hippocampal, cortical, reward, and serotonergic circuits 101 ; these may be susceptible to epigenetic influences. 62 
Brain circuits
The logical assumption that a particular brain circuit or pattern of connectivity is implicated in a defined and replicable pattern of behavior-here referring to chronic pain or analgesic effectswould seem a rational basis for the understanding of a "relative pain state." Such a state may be defined as reactive, able to alter connectivity through synaptic interactions, and by implication become adaptive, able to produce pain relief, either endogenously or in response to treatment. This may be conceptualized as reaching a state equivalent to a genetic brain disease (eg, schizophrenia or autism), where both brain structure and function become "stuck" resulting in the phenotypic expression of the specific disease. In the clinical examples noted above, specifically thalamic stroke, a sudden event results in damage to multiple neuronal circuits. As noted in the evaluation of poststroke patients, diffusion tensor imaging shows a reduction in sensory thalamocortical fibers with associated altered functional changes in the cingulate and posterior parietal lobules, 232 suggesting a change in connectivity that may underlie disruption (eg, potential functional deafferentation) of circuits contributing to the pain state. Similar anatomical-functional alterations have been shown following a peripheral lesion (trigeminal nerve) in trigeminal neuralgia. 63 Although improved imaging will contribute to further understanding of how these changes take place at an obvious level (ie, a measurable lesion), more subtle changes observed in whole brain 115 or forebrain regions, even small ones (such as the habenula) in chronic pain 86 may contribute to major increases in brain dysfunction. In addition, in responsive individuals, treatment may induce rapid changes (ie, within days or weeks) in gray-matter volume and functional connectivity in Figure 2 . Top: Multiple interactions-disease (pain), effectors (stress, genetic etc.), and downstream modulation (epigenetic changes). The term "epigenesis" as used here refers to potential changes that may contribute to altered cellular/neuronal function through nongenetic influences on gene expression (see text). Bottom: Weighting of interactions has a different effect on pain. Left panel: Increased pain due to an altered immune responsivity due to aging: In this example, age and immune response are abnormal. In some cases, the altered immunity is protective. For example, in young (neonatal) animals and children, the propensity to develop neuropathic pain after surgery may be diminished, based on processes that include altered T lymphocyte responses but is a major contributor to neuropathic pain adults. 51 Middle panel: Environmental factors may exacerbate psychological factors leading to great pain: Parental-child and other relationships may contribute to processes such as fear-avoidance exacerbation of pain. 270 Right panel: Decreased pain based on genetic profile: In humans 155 and rat strains, 154, 235 differences in chronic pain have been reported based on altered genetic backgrounds or gene alleles that may be protective. The converse is thus also true that the genetic background may lead to the phenotypic expression of chronic pain and have different risk profiles for severity and progression/chronicity. chronic pain states. 86 Thus, although similar systems may be affected, individuals may be differentially affected based on their "synaptic state." The latter, as noted in the previous section, may be modified by genetic, epigenetic, and other environmental processes including tissue damage producing a new stressor on this "biomic" state. The concept of reactive synaptogenesis may be a principle underlying how a new stressor (eg, postsurgical pain) acts on an individual's underlying biomic state and may produce a failed state of a new and nonadaptive condition in some chronic pain patients.
Individual neurons contribute to neuronal assemblies that function together: these local network processes may regulate larger networks in a complex process that may be adaptive or maladaptive. Such regulation is through synaptic sprouting or pruning in response to multiple stressors that modulate the neural allostatic state. Changes may alter synaptic efficiency and increase risk of a disease phenotype. Indeed, short-term synaptic plasticity in cortical brain regions can be produced in rodent models, 123, 137 including in those pathways (eg, thalamiccingulate) involved in nociceptive processing. 237 These changes can be modified by environmental stress, or neurotransmitter (eg, dopamine) stress is also an environmental determinant of longterm potentiation at these cortical synapses. 138 Synaptogenesis is a very dynamic process. 118 For example, deafferentation, as a result of alteration in dendritic/axonal connections, may be functionally restored through intact axons. 119, 254 These changes may depend on "experience" including past and new events 102 and can be observed in vivo using 2-photon imaging. 128 Taken together, changes in network function may take place through changes in synaptic strength in existing synapses in addition to loss and gain of synapses that may then have an impact on connectivity. Indeed, local changes can thus alter whole networks. 37 The alterations form a basis for understanding risk of pain but also how pain conditions may get stuck. Models of how these changes may take place are discussed below.
Endogenous regulators: relative opioidergic and dopaminergic tone
The two systems, opioidergic and dopaminergic, are believed to play a significant role in pain chronification, dopamine being involved in both reward/antireward and pain processing. 31 Opioids are ubiquitous in the brain, including in regions involved with nociception/pain transmission, 92 placebo, and reward and aversion processes. 16 Alterations in opioid receptor interactions with endogenous or exogenous opioids contribute to an overall "opioid tone" that depends on receptor subtype and on receptor density. This may be analgesic (eg, endogenous analgesia), 189 placebo, 271 or hyperalgesic (eg, withdrawal 5 pain). Evidence suggesting a hypodopaminergic state in chronic pain comes from both preclinical 199 and clinical 258 data. Pain syndromes that have shown altered dopaminergic processing include burning mouth syndrome, 117 atypical facial pain, 116 and fibromyalgia. 278 The diminished dopaminergic tone contributes to the increased sensitivity of pain patients to emotional stimuli, somewhat similar to the phenomenon of denervation hypersensitivity. Examples of pain susceptibility with altered endogenous opioidergic or dopaminergic processing are provided below:
Opioidergic tone
Alterations in opioid receptor interactions with endogenous or exogenous opioids contribute to an overall "opioid tone," as noted above. Thus, the level and type of opioid present may Figure 3 . Synaptic connections, neural assemblies, and neural networks. Synaptic complexity: The figure summarizes the complexity of normal (red) and abnormal (purple) neuronal dendrites. Altered synaptic connections take place in the pathways (functional or structural connectivity) in pain chronification in sensory, 261 thalamus, 158 somatosensory cortex, 99 and in emotional pathways (eg, nucleus accumbens 87 ). Neural assemblies: Neural assemblies represent populations of cells within a structure that usually function in a coordinated or synchronized/temporal manner. Such assemblies usually act in a similar to produce a specific action or function in a manner based on past "experience" or memory. The concept is that the assembly is interdependent and cohesive as a result of the pattern of synaptic connections. As such, assemblies may falter when synaptic processes are diminished. Neurons within assemblies may activate or inhibit in a cohesive manner, other members of the assembly. Brain regions where these assemblies have been studied include the hippocampus. 120, 181 Neural networks: Neural networks are dependent on connectivity. When there are alterations in this connectivity, presumably originating at the level of synaptic changes, these networks are altered. Neural networks can be measured using fMRI and represented as resting state networks. A correlation with anatomical changes has been shown using the same methods, supporting the notion of altered gray-matter changes underlying changes in connectivity. 36 In chronic pain, these are disrupted, eg, in painful diabetic neuropathy, 43 chronic back pain, 10 fibromyalgia, 144 and complex regional pain syndrome. 15 fMRI, functional magnetic resonance imaging. contribute to a basal state or ecosystem that can be "tripped" in susceptible individuals. Two examples of altered opioidergic tone include (1) patients with particular single-nucleotide polymorphism (SNP) opioid profiles and pain susceptibility 198 , and (2) increased sensitivity to experimental pain in currently using or "recovered" methadone/heroin addicts. 50, 70, 216 The recent imaging work has shown significant alterations of brain structure and function in individuals taking opioids, 266 perhaps suggesting that changes in opioidergic tone may contribute to significant differences in response to pain through altered receptors or endogenous opioid extent in sensory (eg, ventroposterolateral thalamus) and emotional (eg, nucleus accumbens), or descending modulatory (eg, periaqueductal gray) circuits. Defining an easily measurable sensitive phenotype for pain susceptibility is clearly one of the great steps forward in the pain field. A recent report evaluating pain susceptibility included functional imaging and genetic data in over 600 healthy subjects, evaluating the development of pain in previously pain-free individuals. 198 The contributions of SNPs (genetic) of the mu opioid receptors to pain and state-of-the-brain reward systems and their interactions provided revealing insights into endogenous predisposition to chronic pain: the mu opioid SNP rs563649, associated with opioid receptor mu1 gene, may be a predictor of persistent pain. Thus, rs563649 SNP analysis may serve as a marker for the evolution of pain with time.
Dopaminergic tone
Acute nociception is carried through ascending spinal tracts to the somatosensory cortex; its sensory/affective components are processed in the classical reward/motivational centers namely, the amygdala (fear and emotion), nucleus accumbens (reward, motivation, and avoidance), cingulate (fear avoidance, unpleasantness, interoception, and motor orientation), insula (subjective experience and interoception), reticular formation nuclei (arousal and vigilance), parabrachial nucleus and hypothalamus (autonomic and neuroendocrine stress responses), and habenula (aversion and reduced motivation). Thus, resulting "pain" is embedded within extensive emotion/reward/motivation circuitry, representing a neural network responsible for continued existence of individuals and species through pursuit of food, water, and sex as well as through learning, decision-making, adaptation to stress, and the urgent avoidance of harm.
Acute pain activates dopamine transmission in the mesolimbic dopaminergic circuits through enhancement of extracellular dopamine release and/or by potentiation of dopamine receptors' affinity and activity. Chronic pain exerts an opposite action by decreasing dopaminergic neurotransmission and is accompanied by decreased ability to experience joy and pleasure along with diminished motivation towards normally pleasurable stimuli, ie, to say reward deficiency. 81, 83 Such a tonic hypodopaminergic state sets in motion robust augmentation of phasic dopamine responses to pain and through conditioning, to pain-related cues manifested in overlearned motivational significance of painconditioned cues and sensitized incentive salience attributed to pain and to pain-related stimuli. 84 Such aberrant learning and incentive sensitization mechanisms are added or synergized by cross-sensitization to stress, 31, 81 ie, antireward processes, which are autonomous feed-forward loop, whereby previous exposure to one stimulus (eg, pain) increases subsequent response to itself and to a different stimulus (eg, stress). Addiction models including reward deficiency, 48 incentive sensitization, 219 aberrant learning, 134 and antireward 151 models, have heuristic value for understanding dopaminergic effects in chronic pain.
Addiction models have heuristic value because the same neural systems are usurped by addictive drugs. 133 Indeed, both pain and drugs are associated with massive dopaminergic surges in reward, motivation, and learning regions, albeit not entirely on the same timescale. 226 By their chronic nature, this leads to an allostatic load 31, 81 derived from such pervasive neuroadaptations as reward deficiency (ie, diminution of drives and anhedonia), antireward (ie, stress-like emotional states), incentive sensitization (ie, assignment of excessive motivational value to pain), and aberrant learning (ie, difficulty in extinguishing the motivational significance of pain-conditioned cues) prominently reflected in negative affect, rigidly focused motivational states, eg, craving, or its pathophysiologic analogs of the interpretation of all pain as harm to be assertively avoided. Hence, as with drug addiction, pain chronification may be determined by a relative preponderance of the allostatic neuroadaptations as opposed to homeostatic adjustments.
In some instances, it might be possible to postulate specificity of the acute and chronic pain mechanisms. As discussed above, their dissociability is underscored by qualitatively different allostatic neuroadaptational characteristics along with preservation of the emotional awareness of pain notwithstanding extensive bilateral damage to the amygdala, insula, and cingulate. 91 An alternative continuum interpretation is that chronic pain is an exaggerated form of the acute pain process. Compatible with the latter assumption, development of pain chronicity is related to the intensity or duration of the acute pain. 2 In sum, the existing preclinical and human data are still far from being conclusive on the dissociation of acute and chronic pain, and the theoretical considerations are not unambiguous. Figure 4A summarizes the interactions of multiple processes that may contribute to increased or decreased pain. But what pushes the system to stick remains the critical question and indicates possible targets. Below, we discuss potential processes (that may sustain or limit adaptive plasticity) that may afford a direction for research to try to disentangle the puzzle.
Pain unstuck: potential research targets

Energetics and mitochondria
We know that "…the transmission of information across neuronal synapses is an energetically taxing business" 228 and that the "dendritic distribution of mitochondria is essential and limiting for the support of synapses." 161 Given these 2 findings, it is plausible that a decrement in neuronal energetics, manifested as "mitochondrial malaise," may influence the form of neuronal synaptic connections 161 in chronic pain. Altered energetics means that the system for building connections for adaptive changes in neurons is malfunctioning.
Managing synaptic connectivity
In conditions in which pain sticks, there may be a freeze on synaptic plasticity. This has been observed for other brain diseases such as Parkinson disease. 207 In the latter, it is believed that changes in neuronal excitability may contribute to maladaptive forms of synaptic plasticity. This may be interpreted as pain memory, but this notion is perhaps erroneous because the process is one that is more ongoing, initially starting in a healthy condition. The ongoing process itself may contribute to a memory-altered local and general circuits-that are continually reporting a distress signal. Some have suggested that this is really one of the abnormal processes of error detection that have been considered in a number of neurological and psychiatric conditions, 148 as well as in migraine. 30 Other examples may relate to parallel processes where synaptic connectivity slows down and is not adaptive. One is aging 66 where there is a reduction in the capacity of dendritic spine plasticity that may relate to vulnerability to, or persistence of, a condition. 22 In this context, a new maladaptive zone becomes the norm and is not easily modified or remodeled. 282 The data seem to confirm that such alterations lead to diminished plasticity. 255, 257 The memory for the newly maladapted state maintains the state as exemplified in a rat model of spinal cord injury. 256 
Restoring maladaptive networks
Some chronic pain processes occur immediately after nerve damage (eg, thalamic stroke, chemotherapy-induced neuropathy). Either as drivers of central brain changes or as direct effects on brain or spinal cord tissue, a chronic pain state is established. In support of the idea of maladaptive brain networks (centralization of pain), there are a number of themes to address: (1) Imaging studies have noted altered resting state networks in chronic pain 15, 42, 252 ; (2) certain nonpainful conditions such as major depressive disorder may lead to generalized pain, suggesting an evolution of neural connections that contribute to a comorbid pain phenotype; (3) "corrupted" networks may trend to normalization together with symptomatic relief in chronic conditions such as CRPS, 15 fibromyalgia, 98 and chronic migraine, 130 suggesting that undoing the reversal of altered connectivity or the remodeling of new connectivity may take place; and (4) that certain interventions including pharmacological (eg, ketamine 14 ), electrophysiological {eg, electroconvulsive therapy 172 
Conclusions
Current pain treatments are largely free of any neurobiological concerns. We currently lack any specificity of treatment to mechanism, or of class of behavior to underlying biological state. We move closer to that specificity. Resting state networks provide one approach to define which systems are most affected (eg, salience, sensorimotor, cognitive, motivational, etc.) and to target single or combined treatment approaches. In a recent article from our group, we evaluated the effects of treatments on the reconstitution of abnormal resting states in patients with chronic pain. 15 In line with this thinking, in animal models of neurological disease, the reversal of molecular, electrophysiological, and behavioral deficits have been shown. 39 Most studies have only considered independent processes in preclinical and clinical studies. Epigenetic processes including DNA methylation 218 can be reversed 221 ; stress can be controlled; and psychological therapy can reduce anxiety, depression, and disability. 275 As noted by Castren et al., 39 "…targeted pharmacological treatments in combination with regimes of training or rehabilitation might alleviate or reverse the symptoms of neurodevelopmental disorders." If one considers the theme forwarded by Gustin et al. 114 related to the 4 main processes that are abnormal in chronic pain (ie, sensory-discriminative, cognitive/evaluative, affective/motivational, and psychosocial sate), it would seem intuitive that having a measure of each and 185 (see B, below). The latter may become maladaptive when the process of responsiveness to stress/ pain fails. These changes are manifest as alterations of brain structure and function that in its "terminal" formulation is stuck and very difficult to treat. Multiple treatment options (A-E) are noted in the measures and treatments (detailed in B below). The current approaches are defined under Rational Medicine where all forms of treatment are or should be based on randomized control trials wherever possible. More aggressive treatments represent a failure to reverse pain chronification. Ideally specific, highly effective treatments, with tolerable or minimal side effects will become available. Markers of pain chronification have not reached a "biomarker status" include clinical, 223 treatment resistance, 72,147 psychological measures, 76, 277 physiological measures (eg, measures of altered descending modulation 204, 248 ), and brain measures. 26, 267 (B) Treatment approaches: Treatment is based on the nature of the individual's resistance/resilience that is modified by a number of allostatic phenomena that include (I) Biological state-pain process, genetic constitution, epigenetic modifications, general health all contribute to the biological state of an individual; (II) Psychological state-Multiple psychological processes contribute to increased risk for pain chronification including fear of pain 239 or catastrophizing 212 , anxiety and depression, 260 and previous pain 124 or trauma, including torture 274 ; (III) Physiological state-Although robust clinical trials are still needed, a number of physiological processes that may contribute to either enhancing or making the condition worse including sleep hygiene, 94 exercise, 104 and diet 180 ; (IV) Socioeconomic state-Pain may be made worse by socioeconomic stressors such as work status, family, income, and educational standing. 217 A summary of premorbid, pain initiation, and postmorbid approaches have been reviewed in the context of the wounded warrior.
its relative contribution to brain changes allows for targeted therapy that would of necessity require multimodal approaches. Such a strategy may make it likely that the "pain chronifiers" (eg, allostatic load) can be evaluated and married to a neural systems approach because these targets may direct treatment profiles (eg, CBT and medication for altered cognitive evaluative processing). However, as is the case with complex phenomena with multiple interacting and usually asymmetric processes, the effects of one may have multiple effects on others. Specifically, one treatment may enhance the effects of the other, eg, "…antidepressants act permissively to facilitate environmental influence on neuronal network reorganization and so provide a plausible neurobiological explanation for the enhanced effect of combining antidepressant treatment with psychotherapy." 40 Measures such as DNA methylation and cortisol levels may provide insights into previous or ongoing stressors. 209 Definitions of sex-related changes including epigenetics relate to the previous example 183 and may provide insights into female predominance in chronic pain.
As with pharmacotherapy, there is an urgent need for a neurobiologically informed psychotherapy. Although there is consensus that psychological interventions can effect meaningful change, it is unclear whether active psychotherapeutic rehabilitation is brain altering in any sustainable way, or indeed whether it is meaningful to identity such changes. That research has not been performed. We recently argued that there should be a halt on psychological treatment development for chronic pain until the science improves, in part by a better translation between preclinical mechanism studies and clinical intervention studies. 74 A closer partnership between behavioral and neurobiological science will benefit both. Furthermore, the absence of long-term follow-up data in CBT for chronic pain remains a gap in our knowledge. Some insights may be garnered from the long-term effects of CBT on depression. In the CoBalT trial, eg, patients were followed for 3.5 years after 12 to 18 CBT sessions with good effect. Interestingly, CBT, one of the few psychological approaches to be evaluated in RCTs, 95, 275 has also been shown, in relatively short studies (approximately 11 weeks), to alter gray matter or improve functional connectivity in chronic pain patients. 233, 236 These studies suggest structural and functional changes with associated improvement in pain patients but do not differentiate responders from nonresponders (when pain gets stuck). However, for other psychological treatments, RCTs are for the most part lacking. 77 This field is in its infancy and is a promising area for development.
A critical first step is to place the biological function of pain as a motivational drive to avoid harm at the center of any psychotherapeutic attempts to alter sensation, "unlock" fixed pain behavior, or promote resilience in a system used to prioritizing return to homeostasis. 78 Next-generation behavioral medicine will move away from encouraging acceptance of pain as inevitable but instead will seek to alter that inevitability. To that end, we have recently put forward a new model, wherein pain comprises 2 neuroanatomical systems: subcortical circuits mediating unconscious and automatic threat-related physiologic and behavioral responses in conjunction with closely linked, yet potentially dissociable higher corticolimbic networks producing conscious pain experiences with corresponding sets of drives and behaviors. 82 The proposed model supports the use of both psychosocial and pharmacological interventions for amelioration of chronic pain problems. 83 Patients with predominately subcortical unconscious pain components may not be amenable for certain types of psychological treatment, and the time is ripe to explore therapeutic options for these patients. 82 The opportunities for integrated personalized medicine for pain are indeed exciting. 25 In an ideal world, optimal pain management would include (1) understanding an individual's genetic (genetic evaluations may only provide some insight to risk of chronic pain) and psychological history and status 171 ; (2) aggressive perioperative processes including understanding the nociceptive load during surgery 29, 153 ; (3) therapies for any early onset pain; and (4) a greater understanding of the role of aggressive approaches to "reset" brain function, as has been attempted in for some conditions with transcranial magnetic stimulation, 8 or even electroconvulsive therapy. 250 These themes are presented in Figure 4 as 2 opposing processes-"Drivers for Change" (Fig.  4A) that may induce chronification and potential biomarkers for these, and "Treatment Approaches" (Fig. 4B ) that recapitulate the model presented previously. 105 The neurobiology of drive and allostasis, used to account for stickiness in pain experience and disability behavior, has important implications: it can forge insight into the problem of how pain chronifies, help explain treatment efficacy and failure, and can support our efforts to carve out much needed new avenues for clinical development.
